REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hubei Biocause Heilen Pharmaceutical Co., Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hubei Biocause Heilen Pharmaceutical Co., Ltd Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Hubei Biocause Heilen Pharmaceutical Co., Ltd. focuses on the R&D, production and sales of chemical API and preparation products. The company was founded in 1995 and headquartered in Jingmen City, China.

Headquarters
No. 122, Yangwan Road, Duodao District, Jingmen high tech Zone, Jingmen City, Hubei Province
Jingmen; Hubei; Postal Code: 448000

Contact Details: Purchase the Hubei Biocause Heilen Pharmaceutical Co., Ltd report to view the information.

Website: http://www.biocause.com

Basic Information
Total Employees:
Purchase the Hubei Biocause Heilen Pharmaceutical Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Hubei Biocause Heilen Pharmaceutical Co., Ltd report to view the information.
Registered Capital:
Purchase the Hubei Biocause Heilen Pharmaceutical Co., Ltd report to view the information.
Financial Auditors:
Purchase the Hubei Biocause Heilen Pharmaceutical Co., Ltd report to view the information.
Incorporation Date:
December 29, 1995
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
38.25%
Purchase this report to view the information.
12%
Purchase this report to view the information.
5.63%
Purchase this report to view the information.
4.5%
Purchase this report to view the information.
4.5%
Subsidiaries
Hubei Baike Pharmaceutical Trading Co., Ltd.
100%
Wuhan Baike Drug Development Co., Ltd.
100%
Wuhan Hendi Drug Development Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Hubei Biocause Heilen Pharmaceutical Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-28.57%▼
Total operating revenue
-28.06%▼
Operating profit (EBIT)
-7.84%▼
EBITDA
-6.37%▼
Net Profit (Loss) for the Period
-6.37%▼
Total assets
2.48%▲
Total equity
3.37%▲
Operating Profit Margin (ROS)
7.23%▲
Net Profit Margin
6.43%▲
Return on Equity (ROE)
-0.16%▼
Quick Ratio
0.53%▲
Cash Ratio
0.44%▲

Similar companies

Shanghai Pharmaceuticals Holding Co., Ltd
 
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
 
Zjamp Group Co., Ltd.
Zhongzhu Healthcare Holding Co., Ltd
 
Shaanxi Kanghui Pharmaceutical Co., Ltd.
Chemclin Diagnostics Co., Ltd.
 
Bio-Thera Solutions, Ltd.
Pharmaresources (Shanghai)Co., Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo